Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals was a company that focused on developing therapies for inflammatory conditions. The company was dissolved in August 2024 following stockholder approval of a Plan of Dissolution. The remaining assets, primarily cash, are intended for distribution to stockholders after settling legal obligations, subject to court approval. Updates are to be posted on the company's website.
Official Registry
AI Quality Analysis
Trust Score Breakdown
Quick Links
🌟 Vastaavat luotettavat yritykset
Lantern Pharma Inc.
Lantern Pharma is an AI-driven company focused on transforming oncology drug discovery and development. Leveraging their proprietary RADR® platform, which utilizes ~200 billion oncology-focused data points and advanced ML algorithms, they accelerate the creation of precision therapies. Their pipeline includes drug candidates across multiple cancer indications, with one in Phase 2 clinical testing, aiming to reduce costs and timelines. They collaborate with various institutions to advance their AI precision oncology platform.
Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals aims to be a leading innovator in the self-care market, driving expanded access to key prescription pharmaceuticals as Over-the-Counter treatment options. They focus on enhancing consumer reach to medications via OTC drug programs and democratizing healthcare by making medications more accessible without a prescription.
OVATION SCIENCE INC.
Ovation Science Inc. is capitalizing on its patented Invisicare® skin delivery technology, disrupting the topical market with its advanced science. They provide pharmaceutical-grade technology to global licensees, resulting in high-quality, efficacious topical and transdermal products. The company is an innovative player in drug delivery systems.